Cargando…
Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.
Primary colorectal carcinomas of an unselected group of 159 patients 126 of whom could be curatively resected were examined for the expression of MHC class I antigens with monoclonal antibody W6/32 directed against a non-polymorphic determinant of HLA-A,B,C heavy chain. One hundred and nine (68.6%)...
Autores principales: | Stein, B., Momburg, F., Schwarz, V., Schlag, P., Moldenhauer, G., Möller, P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246570/ https://www.ncbi.nlm.nih.gov/pubmed/2839218 |
Ejemplares similares
-
HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
por: van den Ingh, H. F., et al.
Publicado: (1987) -
Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker.
por: Moldenhauer, G., et al.
Publicado: (1987) -
Human Leukocyte Antigen (HLA) Influence on Prognosis of Autoimmune Hearing Loss
por: Psillas, George, et al.
Publicado: (2021) -
HLA-E Peptide Repertoire and Dimorphism—Centerpieces in the Adaptive NK Cell Puzzle?
por: Rölle, Alexander, et al.
Publicado: (2018) -
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
por: López-Nevot, M. A., et al.
Publicado: (1989)